Data do not support widespread Covid vaccine boosters right now, outgoing FDA leaders write in the Lancet
Even with the Delta variant, vaccine efficacy against severe Covid-19 is so high that booster doses for the general population are not appropriate at this …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
